Business Description
Thyrocare Technologies Ltd
ISIN : INE594H01019
Total Employee Number:
1,906Compare
Compare
Traded in other countries / regions
THYROCARE.India IPO Date
2016-05-09Description
Thyrocare Technologies Ltd is a diagnostics & research company. The company has three business segments: Diagnostic Testing Services, Imaging Services, and Others: Sale of testing equipment and consumables. The Diagnostic Testing Services segment provides Diagnostic and testing services, selling of consumables used for the collection and promotion of the pathology segment. The company majorly earns the majority of its revenue from the Diagnostic Testing Services segment. The Imaging Services segment operates Diagnostic and imaging services, selling of radio-pharmaceuticals, and selling of consumables for reporting. The Other business segment is engaged in the selling of glucometers and glucostrips under the brand name Sugarscan. The company earns the vast majority of its revenue in India.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.56 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | 0.18 | |||||
Interest Coverage | 72.66 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 33.57 | |||||
Beneish M-Score | -2.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.5 | |||||
3-Year EBITDA Growth Rate | 28.2 | |||||
3-Year EPS without NRI Growth Rate | 38 | |||||
3-Year FCF Growth Rate | 30.8 | |||||
3-Year Book Growth Rate | 3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 16.78 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 15.94 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.85 | |||||
9-Day RSI | 62.77 | |||||
14-Day RSI | 60.02 | |||||
3-1 Month Momentum % | 39.5 | |||||
6-1 Month Momentum % | 17.64 | |||||
12-1 Month Momentum % | 35.93 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.39 | |||||
Quick Ratio | 2.95 | |||||
Cash Ratio | 2.1 | |||||
Days Inventory | 73.65 | |||||
Days Sales Outstanding | 32.63 | |||||
Days Payable | 115.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.9 | |||||
Dividend Payout Ratio | 0.88 | |||||
3-Year Dividend Growth Rate | 23.1 | |||||
Forward Dividend Yield % | 2.9 | |||||
5-Year Yield-on-Cost % | 6.81 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 2.95 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 73.52 | |||||
Operating Margin % | 24.54 | |||||
Net Margin % | 19.67 | |||||
EBITDA Margin % | 33.19 | |||||
FCF Margin % | 23.2 | |||||
OCF Margin % | 25.72 | |||||
ROE % | 29.36 | |||||
ROA % | 23.08 | |||||
ROIC % | 36.71 | |||||
3-Year ROIIC % | -3880.85 | |||||
ROC (Joel Greenblatt) % | 96.86 | |||||
ROCE % | 36.78 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 54.95 | |||||
Forward PE Ratio | 48.81 | |||||
PE Ratio without NRI | 53.37 | |||||
Shiller PE Ratio | 68.5 | |||||
Price-to-Owner-Earnings | 43.35 | |||||
PEG Ratio | 14.04 | |||||
PS Ratio | 10.81 | |||||
PB Ratio | 15.3 | |||||
Price-to-Tangible-Book | 18.91 | |||||
Price-to-Free-Cash-Flow | 46.71 | |||||
Price-to-Operating-Cash-Flow | 42.13 | |||||
EV-to-EBIT | 40.53 | |||||
EV-to-EBITDA | 31.91 | |||||
EV-to-Revenue | 10.59 | |||||
EV-to-FCF | 42.14 | |||||
Price-to-GF-Value | 1.42 | |||||
Price-to-Projected-FCF | 15.67 | |||||
Price-to-DCF (Earnings Based) | 5.68 | |||||
Price-to-DCF (FCF Based) | 3.32 | |||||
Price-to-Median-PS-Value | 1.36 | |||||
Price-to-Graham-Number | 6.7 | |||||
| Price-to-Net-Current-Asset-Value | 42.54 | |||||
| Price-to-Net-Cash | 129.09 | |||||
Earnings Yield (Greenblatt) % | 2.47 | |||||
FCF Yield % | 2.14 | |||||
Forward Rate of Return (Yacktman) % | -0.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Thyrocare Technologies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 8,290.4 | ||
| EPS (TTM) (₹) | 10.243 | ||
| Beta | 1.1251 | ||
| 3-Year Sharpe Ratio | 0.9 | ||
| 3-Year Sortino Ratio | 1.95 | ||
| Volatility % | 55.16 | ||
| 14-Day RSI | 60.02 | ||
| 14-Day ATR (₹) | 23.542515 | ||
| 20-Day SMA (₹) | 535.865 | ||
| 12-1 Month Momentum % | 35.93 | ||
| 52-Week Range (₹) | 342.55 - 578.25 | ||
| Shares Outstanding (Mil) | 159.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Thyrocare Technologies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Thyrocare Technologies Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 7.000000 Cash Dividend | 2026-06-23 | 544.80 (+0.19%) | ||
| 3:1 Stock Split | 2025-11-28 | 491.70 (-1.69%) | ||
| INR 2.333333 Cash Dividend | 2025-10-24 | 417.30 (-1.78%) | ||
| INR 7.000000 Cash Dividend | 2025-07-25 | 445.68 (+6.88%) | ||
| INR 6.000000 Cash Dividend | 2024-08-16 | 293.23 (+0.00%) |
Show
Entries
Thyrocare Technologies Ltd Frequently Asked Questions
What is Thyrocare Technologies Ltd(NSE:THYROCARE)'s stock price today?
The current price of NSE:THYROCARE is ₹562.85. The 52 week high of NSE:THYROCARE is ₹578.25 and 52 week low is ₹342.55.
When is next earnings date of Thyrocare Technologies Ltd(NSE:THYROCARE)?
The next earnings date of Thyrocare Technologies Ltd(NSE:THYROCARE) is .
Does Thyrocare Technologies Ltd(NSE:THYROCARE) pay dividends? If so, how much?
The Dividend Yield %  of Thyrocare Technologies Ltd(NSE:THYROCARE) is 2.9% (As of Today), Highest Dividend Payout Ratio of Thyrocare Technologies Ltd(NSE:THYROCARE) was 1.59. The lowest was 0.33. And the median was 0.79. The  Forward Dividend Yield % of Thyrocare Technologies Ltd(NSE:THYROCARE) is 2.9%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Thyrocare Technologies Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers